| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 22.284 | 35.187 | 39.354 | 39.558 | 39.536 | 38.833 | 46.262 | 46.084 | 50.921 |
| Total Income - EUR | - | 22.284 | 35.187 | 39.354 | 39.559 | 39.536 | 38.833 | 46.262 | 46.295 | 52.325 |
| Total Expenses - EUR | - | 3.373 | 6.434 | 7.787 | 8.665 | 6.831 | 6.365 | 14.102 | 15.181 | 14.821 |
| Gross Profit/Loss - EUR | - | 18.911 | 28.753 | 31.567 | 30.894 | 32.706 | 32.469 | 32.160 | 31.113 | 37.503 |
| Net Profit/Loss - EUR | - | 18.242 | 28.081 | 31.167 | 30.577 | 32.340 | 32.127 | 31.798 | 30.721 | 35.965 |
| Employees | - | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Neuroclinic Dr. Morar Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 18.824 | 29.354 | 32.463 | 32.917 | 33.774 | 33.762 | 36.663 | 38.762 | 38.171 |
| Inventories | - | 56 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 5.586 | 26.647 | 22.144 | 15.857 | 12.129 | 20.683 | 0 | 35.520 |
| Cash | - | 18.768 | 23.768 | 5.816 | 10.773 | 17.918 | 21.633 | 15.979 | 38.762 | 2.651 |
| Shareholders Funds | - | 18.287 | 28.133 | 31.278 | 30.799 | 32.579 | 32.650 | 32.105 | 35.437 | 36.023 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 542 | 1.221 | 1.185 | 2.118 | 1.195 | 1.112 | 4.558 | 3.325 | 2.148 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuroclinic Dr. Morar Srl